Several factors can influence the efficiency and rate of glucuronidation. These include genetic polymorphisms, age, sex, and the presence of certain diseases. For instance, genetic variations in UGT enzymes can lead to differences in drug metabolism, impacting both efficacy and toxicity. Additionally, certain inhibitors and inducers can modulate UGT activity.
